A payment solution for the actual catalogue
We provide payment solutions for eligible peptide businesses following a product-specific review. We assess what you sell, who buys it, where it is supplied and how it is presented. A research supplier, prescription business and consumer retail operation have different requirements. Our approach keeps the payment proposal connected to the actual catalogue rather than relying on a broad wellness or supplement label.
Product presentation and intended use
We review the consistency of product descriptions, labels, advertising and the customer purchase journey. The business model and intended use need to be clear across those materials. A research label alone does not settle product eligibility. Our underwriting process considers the full presentation and relevant documentation, while permissions and product acceptability remain specific to the jurisdiction and proposed provider arrangement.
Supplier and batch documentation
We assess the available supplier records, product lists and relevant laboratory documentation. Records should identify the item and batch they relate to, so the file supports the catalogue being sold. We consider how those records are maintained when suppliers or products change. Laboratory evidence can support the assessment, but it is not a substitute for the applicable product permissions or provider eligibility requirements.
Checkout and fulfilment
We address your checkout integration alongside shipping territories, delivery expectations and refund handling. Customer support should be able to connect a payment with the order, product and fulfilment outcome. The proposed payment flow must reflect the approved business and catalogue. We discuss required currencies, methods and transaction estimates as part of that operating picture.
Catalogue changes and continuity
We make product scope part of the commercial review. New compounds, suppliers, claims or territories can change the assessment and may require confirmation before processing. We work from an accurate description of the business; restricted products should never be concealed under generic labels. Clear change procedures help keep the relationship aligned as the catalogue develops.
Build a product-to-payment application file
We assess the actual peptide catalogue, the contracting seller and the way products are presented to customers. Organise each product reference with its website listing, supplier information and relevant batch records. Distinguish current stock from planned additions and identify documents that apply only to one batch. We review those records in the context of the proposed business, rather than treating a laboratory report as a substitute for product eligibility. Include customer markets and the parties responsible for fulfilment in the same application description.
Match commercial terms to the fulfilment cycle
We bring stock availability, order timing, refund obligations and settlement requirements into the acquiring discussion. Explain whether goods are ready to dispatch, supplied after an order or fulfilled by another organisation. Your proposal should address applicable fees, any reserve conditions, settlement timing and approved scope in relation to that model. We do not promise a standard reserve or guaranteed acceptance for a product category. Written terms and individual underwriting define the available arrangement for your business.
Connect the catalogue, checkout and dispatch record
We support the checkout discussion around the products and fulfilment model presented for review. A merchant should be able to connect an ordered item with the product reference, customer confirmation and relevant dispatch record. Explain how the store handles stock changes, delayed orders, cancellations and refunds. The gateway and platform functions depend on the selected implementation. Test those operational exceptions alongside successful payment so your team can distinguish a payment issue from a delivery or catalogue issue.
Keep product and marketing changes within review
New product names, suppliers, presentations and customer territories can change the business previously assessed. We address those developments before they become assumed extensions of an existing account. Keep product-page versions, supplier records and fulfilment responsibilities aligned with the live catalogue. If your commercial team changes how an item is described, include that change in the review conversation. Payment processing does not itself establish permission to sell a product, and this service provides no peptide medical-use advice.
Start your eLotPay enquiry
Prepare your company country, website, customer markets, expected activity and essential payment requirements. Include the issue you are trying to solve, such as a new checkout, additional methods or a different settlement need. Our business-brief tool organises those details into a download for your next discussion. It currently saves the file on your device rather than submitting an application online. Do not include card details, passwords or identity documents in the brief. Any subsequent document sharing should use the agreed secure onboarding channel.
Product scope your teams can maintain
We address the connection between the approved catalogue and the information held by your commercial and fulfilment teams. Product identifiers, supplier changes and batch references need a coherent record. We consider how a payment can be connected with the item ordered and the fulfilment outcome when an enquiry occurs. The proposed arrangement should reflect the products actually being sold.
Marketing aligned with the payment relationship
We review the purchase journey as a whole, including landing pages and claims that influence customer expectations. A catalogue update may change more than the checkout description. We make that context part of the business review so the agreed activity remains clear across the website, supplier records and processing arrangement. We keep the next step practical: define the business requirement, establish the available structure and set out the responsibilities in writing. The review should give your team a clear basis for evaluating the arrangement, including what is included and what remains conditional. Our focus is a payment relationship that reflects the business you operate.
Frequently asked questions
Does a laboratory report establish product eligibility?
No. We assess product records alongside the catalogue, website presentation, seller, customer markets and fulfilment model. A report supporting one batch should not be presented as evidence for unrelated items. Documentation helps an assessment; it does not guarantee approval or establish permission to sell a product.
What should I prepare for a peptide payment assessment?
Prepare the legal seller, website, current catalogue references, supplier and relevant batch records, intended customer markets and fulfilment responsibilities. Identify missing or outdated documents explicitly. Our product-documentation guide shows how to connect those records without sending sensitive documents through the downloadable brief.
Can I add another peptide product after activation?
Bring new products, suppliers, presentations or customer territories into the review before assuming an existing arrangement covers them. We assess the effect on the approved business scope with the relevant providers.
Is the business brief an online application?
No. The brief creates a file on your device. It is not sent to eLotPay or a provider. Any later document exchange should follow the agreed secure onboarding route.